1. Home
  2. VIVS vs DGLY Comparison

VIVS vs DGLY Comparison

Compare VIVS & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVS
  • DGLY
  • Stock Information
  • Founded
  • VIVS 2007
  • DGLY 2004
  • Country
  • VIVS United States
  • DGLY United States
  • Employees
  • VIVS N/A
  • DGLY N/A
  • Industry
  • VIVS Biotechnology: Biological Products (No Diagnostic Substances)
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • VIVS Health Care
  • DGLY Technology
  • Exchange
  • VIVS Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • VIVS 4.2M
  • DGLY 4.1M
  • IPO Year
  • VIVS N/A
  • DGLY N/A
  • Fundamental
  • Price
  • VIVS $1.45
  • DGLY $2.23
  • Analyst Decision
  • VIVS
  • DGLY
  • Analyst Count
  • VIVS 0
  • DGLY 0
  • Target Price
  • VIVS N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • VIVS 64.3K
  • DGLY 467.9K
  • Earning Date
  • VIVS 07-07-2025
  • DGLY 08-15-2025
  • Dividend Yield
  • VIVS N/A
  • DGLY N/A
  • EPS Growth
  • VIVS N/A
  • DGLY N/A
  • EPS
  • VIVS N/A
  • DGLY N/A
  • Revenue
  • VIVS $144,000.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • VIVS $42.38
  • DGLY N/A
  • Revenue Next Year
  • VIVS $15.42
  • DGLY N/A
  • P/E Ratio
  • VIVS N/A
  • DGLY N/A
  • Revenue Growth
  • VIVS 32.11
  • DGLY N/A
  • 52 Week Low
  • VIVS $1.41
  • DGLY $1.93
  • 52 Week High
  • VIVS $21.96
  • DGLY $265.00
  • Technical
  • Relative Strength Index (RSI)
  • VIVS N/A
  • DGLY 24.67
  • Support Level
  • VIVS N/A
  • DGLY $2.21
  • Resistance Level
  • VIVS N/A
  • DGLY $2.59
  • Average True Range (ATR)
  • VIVS 0.00
  • DGLY 0.26
  • MACD
  • VIVS 0.00
  • DGLY 1.82
  • Stochastic Oscillator
  • VIVS 0.00
  • DGLY 5.04

About VIVS VivoSim Labs Inc. Common Stock

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: